Mnemo Therapeutics
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7-11 Boulevard Haussmann, Paris, Ile-de-...Website
www.mnemo-tx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Mnemo Therapeutics
Founded in 2019, based out of Paris, France, Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible cures. With its EnfiniT platform, a drug discovery engine, Mnemo applies a novel, integrated approach to cell therapy.Explore more
Popular SearchesMnemoSIC Code 87,873NAICS Code 54,541Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mnemo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Mnemo Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Mnemo Therapeutics has new funding data
Earning: See what the market has to say on Mnemo Therapeutics recently announced quarterly report
Product Launch: Get notified when Mnemo Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Mnemo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Mnemo Therapeutics
Click to see if Mnemo Therapeutics had a recent Job posting/layoffs
Check if Mnemo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Mnemo Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mnemo Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mnemo Therapeutics.
Mnemo Therapeutics financials insights
Gather financial insights about Mnemo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$90M
Mnemo Therapeutics Tech Stack
A closer look at the technologies used by Mnemo Therapeutics
See more technologies
Most Recent Scoops
New Hire
Executive Move
Lateral Move
Executive Move
New Hire
Executive Move
Lateral Move
Executive Move
New Hire
Executive Move
Mnemo Therapeutics News & Media
Mnemo Therapeutics and Institut Curie Announce Two Key Publications in Science Immunology Highlighting Novel Approach to Identify Unknown, Therapeutically Relevant Cancer-Specific Targets
-Studies are the first to confirm TE-exon splicing junctions can help differentiate tumors from healthy tissue, potentially solving a longstanding challenge for the field of immuno-oncology- -Results further confirm "grey genome" can be mined for meaningful cancer targets, offer a...Mnemo Therapeutics Appoints Christine Foster, Ph.D. and Co-Founder Sebastian Amigorene, Ph.D. to Key Leadership Roles
PARIS, Nov. 30, 2022 /PRNewswire/ -- Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced the appointment of Christine Foster, Ph.D. to the role of Chief Business Officer. Foster is a seasoned business leader with more than 30 years of...Inactivation of Suv39h1 Enhances Anti-Tumor Immune Response by Increasing T Cell Activity and Decreasing T Cell Exhaustion During Anti-PD-1 Treatment
PARIS, July 6, 2022 /PRNewswire/ -- Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced a publication in Nature Communications demonstrating that the histone lysine methyltransferase enzyme Suv39h1 plays not only a key role in T cell...Mnemo Therapeutics Identifies Possible New Class of Cancer Therapeutic Target
The company has identified numerous immunogenic peptides derived from transposable elements at the surfaces of cancer cells.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Mnemo Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2019, based out of Paris, France, Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible cures. With its EnfiniT platform, a drug discovery engine, Mnemo applies a novel, integrated approach to cell therapy.... Read More
